| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Parshall B Lynne is a Director at IONS, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 42 sales. Those positions are worth an estimated $4.7M at current prices.
Our model assigns Parshall B Lynne a strong insider score of 74/100, based on 20 past trades. Over a 12-month horizon, 93.3% of those trades were profitable, with an average 12-month return of +24.7%.
Parshall B Lynne's largest disclosed position is in IONS as Director, worth about $4.0M. The recent filings there lean toward selling, a net 246,805 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $59.84 | $299,200.00 | -19.5% | -11.6% | -39.2% | |
| Jul 15, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $55.82 | $279,100.00 | -19.5% | -5.0% | -33.8% | |
| Jul 1, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $54.22 | $271,100.00 | -19.5% | -3.5% | -38.5% | |
| Jun 17, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $52.55 | $262,750.00 | -19.5% | +7.5% | -38.3% | |
| Jun 3, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 5,000 | $48.64 | $243,200.00 | -24.3% | +9.4% | -35.8% | |
| Dec 28, 2023 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 117,638 | $50.48 | $5,938,128.76 | -58.8% | -11.6% | -28.9% | |
| Sep 26, 2023 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 10,000 | $45.13 | $451,268.00 | -10.8% | +10.8% | -11.4% | |
| Sep 1, 2022 | CYTK Cytokinetics Inc | Director | Sale+OE | 30,296 | $52.79 | $1,599,325.84 | -75.2% | -20.9% | -33.0% | |
| Nov 5, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 30,996 | $40.00 | $1,239,840.00 | -86.1% | -21.9% | -8.2% | |
| Oct 19, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 10,332 | $35.73 | $369,206.79 | -67.4% | -8.3% | +33.4% |